News
New Study Combining Prone and Supine MRI
LEBANON, N.H., February 24, 2026–(BusinessWire)–New Study Shows Combining Prone and Supine MRI in Single Session Before Breast Conserving Surgery Provides Highly Accurate Tumor Imagery, Efficiently and Conveniently.
MedTech Strategist - Breast Cancer Innovators
LEBANON, N.H., January 27, 2026–(MedTech Strategist)–Cairn Surgical, Inc., Guides Breast Cancer Surgeons to Cleaner Margins.
CairnSurgical Announces Completion of Enrollment in U.S. Pivotal Trial of Novel BCL System
LEBANON, N.H., January 7, 2026–(BUSINESS WIRE)–Cairn Surgical, Inc., an innovative medical technology firm striving to make breast cancer surgery more precise, announced today that patient enrollment has been completed in the U.S. pivotal trial of its Breast Cancer Locator (BCLTM) System.
New Published Data Shows BCL Dramatically Improves Surgeon Ability To Remove Entire Tumor With Negative Margins
LEBANON, N.H., October 21, 2025– CairnSurgical announced a multicenter study just published demonstrated that the BCL system met its primary endpoint, enabling breast surgeons to successfully remove the entire tumor with negative margins in 94% of patients.
CairnSurgical Achieves ISO 13485 Certification
LEBANON, N.H., July 24, 2025–(BUSINESS WIRE)–Cairn Surgical achieves ISO 13485 certification. [read more via Business Wire]
CairnSurgical announces first commercial use of novel Breast Cancer Locator System
LEBANON, N.H., September 19, 2024–(BUSINESS WIRE)–Cairn Surgical, Inc., an innovative medical technology firm striving to make breast cancer surgery more precise, announced today that the first commercial case using its Breast Cancer Locator (BCL™) System has been performed by Prof. Dr. med. Hisham Fansa, head of the Breast Center and head of plastic surgery at Spital Zollikerberg, Zürich, Switzerland. [read more via Yahoo Finance / Business Wire]
CairnSurgical completes enrollment in European study of novel Breast Cancer Locator system
CairnSurgical completed enrollment its European post-market clinical study
CairnSurgical closes $4.5 million in new financing for novel Breast Cancer Locator System designed to improve breast cancer surgery
Funds to Support Pivotal Trial Completion and Early Commercialization
NH Tech Alliance Names the Breast Cancer Locator as Product of the Year
CairnSurgical wins NH Product of the Year.
MedTech Strategist highlights CairnSurgical
CairnSurgical: Patient-Specific, Real-Time Guidance for Breast Cancer Surgery
CairnSurgical Announces First Patient Treated in Pivotal Clinical Trial of Breast Cancer Locator System
The first patient has been treated in the pivotal clinical trial using the Breast Cancer Locator (BCL) for surgical guidance at Massachusetts General Hospital.
CairnSurgical Completes Series A investment
Celdara Medical announced that the first DRIVEN Accelerator Hub Company, CairnSurgical, Inc., has closed a Series A investment led by Morningside Group. Click to read more.
CairnSurgical Announces First Patients Treated in Europe With Breast Cancer Locator System
System Designed to Reduce the Incidence of Positive Margins – or Cancer Left Behind – After Breast Cancer Surgery
Publications
Barth, RJ Jr, Krishnaswamy, V, Rooney, TB, Fox, MJ, Burman, HEG, Rosenkranz, KM et al.. A pilot multi-institutional study to evaluate the accuracy of a supine MRI based guidance system, the Breast Cancer Locator™, in patients with palpable breast cancer. Surg Oncol. 2022;44 :101843. doi: 10.1016/j.suronc.2022.101843. PubMed PMID:36067629 .
Byrd, BK, Krishnaswamy, V, Gui, J, Rooney, T, Zuurbier, R, Rosenkranz, K et al.. The shape of breast cancer. Breast Cancer Res Treat. 2020;183 (2):403-410. doi: 10.1007/s10549-020-05780-6. PubMed PMID:32656723 PubMed Central PMC8256655.
Barth, RJ Jr, Krishnaswamy, V, Paulsen, KD, Rooney, TB, Wells, WA, Angeles, CV et al.. A Randomized Prospective Trial of Supine MRI-Guided Versus Wire-Localized Lumpectomy for Breast Cancer. Ann Surg Oncol. 2019;26 (10):3099-3108. doi: 10.1245/s10434-019-07531-4. PubMed PMID:31359283 .
Barth, RJ Jr, Krishnaswamy, V, Paulsen, KD, Rooney, TB, Wells, WA, Rizzo, E et al.. A Patient-Specific 3D-Printed Form Accurately Transfers Supine MRI-Derived Tumor Localization Information to Guide Breast-Conserving Surgery. Ann Surg Oncol. 2017;24 (10):2950-2956. doi: 10.1245/s10434-017-5979-z. PubMed PMID:28766199 PubMed Central PMC6015768.
Thill, M, Ghilli, M, Roncella, M, Kelling, K, Fansa, H, Golatta, M, Heil, J et al. A Multi-Institutional Study to Evaluate the Effectiveness and Safety of a Supine MRI-Based Guidance System, the Breast Cancer Locator™, for Breast Conserving Surgery in Patients with Nonpalpable Breast Cancer. Ann Surg Oncol. 2025;32:8636-8643. doi: 10.1245/s10434-025-17513-4.